Simple Summary Cancer survivors can experience neurological complications after
exposure to anticancer therapy. Chemotherapy-induced peripheral neurotoxicity (CIPN) …

Patients with cancer are living longer because of earlier diagnoses and remarkable
improvements in treatments. Unfortunately, both traditional chemotherapies and newer …

This last decade has yielded more robust development of cancer treatments and first-in-
class agents than ever before. Since 2006, nearly one hundred new drugs have received …

Neurotoxicity caused by traditional chemotherapy and radiotherapy is widely recognized in
patients with cancer. The adverse effects of newer therapeutics, such as biological and …

Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …

C hemotherapy is commonly associated with harmful effects to multiple organ systems,
including the central nervous system (CNS). Neurotoxicity may manifest as both acute and …

Patients with cancer often take multiple medications. These medications may be directed at
underlying neoplasms (eg, chemotherapy, hormonal agents, biologic modifiers) or at …

Introduction Treatment-related neurotoxicity is a common side effect in cancer patients.
However, few data are available regarding the risk of several neurotoxicities in patients …

Chemotherapy-induced neurotoxicity is a significant complication in the successful treatment
of many cancers. Neurotoxicity may develop as a consequence of treatment with platinum …

Neurologic dysfunction is a well-recognized adverse effect of cancer therapeutics. The most
common manifestations include peripheral neuropathy and encephalopathy. Often …